Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
6 studies found for:    "Insulin-like growth factor I deficiency"
Show Display Options
Rank Status Study
1 Completed
Has Results
Recombinant Human Insulin-Like Growth Factor (rhIGF-1) Treatment of Short Stature Associated With IGF-1 Deficiency
Conditions: Insulin-Like Growth Factor-1 Deficiency;   Growth Disorders
Intervention: Drug: rhIGF-1 (mecasermin) for a period of 86 weeks
2 Recruiting European Increlex® (Mecasermin [rDNA Origin] Injection) Growth Forum Database - IGFD Registry
Condition: IGF1 Deficiency
Intervention: Drug: Increlex®
3 Terminated IGF-1, IGFBP3, ALS Normative Ranges in Healthy Pediatric Spanish Population
Condition: IGF-1 Deficiency
4 Terminated
Has Results
rhGH and rhIGF-1 Combination Therapy in Children With Short Stature Associated With IGF-1 Deficiency
Condition: Insulin-like Growth Factor-1 Deficiency
Interventions: Drug: NutropinAq® (Somatropin [rDNA origin]);   Drug: Increlex® (Mecasermin [rDNA origin] injection) + NutropinAq® (Somatropin [rDNA origin])
5 Terminated
Has Results
Treatment of Children and Adolescents With Growth Failure Associated With Primary IGF-1 Deficiency
Condition: Growth Disorders
Intervention: Drug: rh IGF-1 (mecasermin)
6 Completed
Has Results
Prepubertal Children With Growth Failure Associated With Primary Insulin-Like Growth Factor-1 (IGF-1) Deficiency
Conditions: Growth Disorders;   Insulin-Like Growth Factor-1 Deficiency
Intervention: Drug: rhIGF-1 (mecasermin, Tercica, Inc.)

Study has passed its completion date and status has not been verified in more than two years.